Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Avid Radiopharmaceuticals
Age
20–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy volunteers had an Mini-Mental State Examination (MMSE) score of ≥ 29;
MCI due to Alzheimer's disease (AD) consistent with National Institute on Aging (NIA)-Alzheimer's Association working group's on diagnostic guidelines for AD (Alzheimer's Dementia 7:270-9, 2011)
Possible or probable AD: Met clinical criteria for possible or probable AD based on the NIA-Alzheimer's Association working group's on diagnostic guidelines for AD (Alzheimer's Dementia 7:263-9, 2011)
You may not be if
Current clinically significant psychiatric disease.
Evidence of structural abnormalities such as major stroke or mass on MRI that would have made a diagnosis of impairment due to AD unlikely or was likely to interfere with interpretation of a PET scan on MRI.
Claustrophobic or otherwise unable to tolerate the imaging procedure.
Current clinically significant cardiovascular disease or clinically significant abnormalities on screening electrocardiogram (including, but not limited to, corrected QT interval \>450 msec).
Current clinically significant infectious disease, endocrine or metabolic disease, pulmonary, renal or hepatic impairment, or cancer
History of alcohol abuse or substance abuse or dependence
Female subjects of childbearing potential who were not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception.
Required medications with a narrow therapeutic window
Received a non-study related radiopharmaceutical imaging or treatment procedure within 7 days prior to imaging session
Receiving any investigational medications or had participated in a trial with investigational medications within the last 30 days
